24/05/2024  21:57:42 Var. - Volume Denaro- Lettera- Capitalizzazione di mercato Dividend Y. Rapporto P/E
1.06USD - 470
Fatturato: 499.17
-Quantità in denaro: - -Quantità in lettera: - 58.4 mill.USD - 2.78

Descrizione business

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products systems and services that meet the ever-changing and rapidly growing needs of health care both today and into the future. Underpinning Enzo Biochem’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Elazar Rabbani
Consiglio di amministrazione
David Bench, Barry W. Weiner, Dieter Schapfel, MD, Kara Cannon
Consiglio di sorveglianza
Dr. Elazar Rabbani, Dov Perlysky, Ian B. Walters, Mary Tagliaferri, Rebecca Fischer
 

Dati aziendali

Name: Enzo Biochem Inc.
Indirizzo: 527 Madison Avenue,New York, New York 10022, USA
Telefono: +1-212-583-0100
Fax: +1-212-679-7999
E-mail: info@enzo.com
Internet: www.enzo.com
Industria: Biotechnology
Settore: Biotechnology
Sub settore: Biotechnology
Fine dell'anno finanziario: 31/07
Flottante libero: 67.10%
Data dell'IPO: -

Rapporti con gli investitori

Name: Steve Anreder
IR telefono: +1-212-532-3232
IR Fax: -
IR e-mail: steven.anreder@anreder.com

Principali azionisti

Freefloat
 
67.10%
Harbert Management Corp
 
11.70%
BlackRock Fund Advisors
 
7.50%
Renaissance Technologies, LLC
 
7.50%
Evermore Global Advisors LLC
 
6.20%